Study profile: the Durban Diabetes Study (DDS): a platform for chronic disease research
View / Open Files
Authors
Hird, TR
Young, EH
Pirie, FJ
Riha, J
Esterhuizen, TM
O'Leary, B
McCarthy, MI
Motala, AA
Publication Date
2016-02-05Journal Title
Global Health, Epidemiology and Genomics
ISSN
2054-4200
Publisher
Cambridge University Press
Volume
1
Number
e2
Language
English
Type
Article
Metadata
Show full item recordCitation
Hird, T., Young, E., Pirie, F., Riha, J., Esterhuizen, T., O'Leary, B., McCarthy, M., et al. (2016). Study profile: the Durban Diabetes Study (DDS): a platform for chronic disease research. Global Health, Epidemiology and Genomics, 1 (e2)https://doi.org/10.1017/gheg.2015.3
Abstract
The Durban Diabetes Study (DDS) is a population-based cross-sectional survey of an urban black population in the eThekwini Municipality (city of Durban) in South Africa. The survey combines health, lifestyle and socioeconomic questionnaire data with standardised biophysical measurements, biomarkers for non-communicable and infectious diseases, and genetic data. Data collection for the study is currently underway and the target sample size is 10 000 participants. The DDS has an established infrastructure for survey fieldwork, data collection and management, sample processing and storage, managed data sharing and consent for re-approaching participants, which can be utilised for further research studies. As such, the DDS represents a rich platform for investigating the distribution, interrelation and aetiology of chronic diseases and their risk factors, which is critical for developing health care policies for disease management and prevention.
Keywords
chronic disease, epidemiology, genetics, population-based, study profile
Sponsorship
The study was supported by the Wellcome Trust (grant number 098051), the African Partnership for Chronic Disease Research (Medical Research Council UK partnership grant number MR/K013491/1), the National Institute for Health Research Cambridge Biomedical Research Centre (UK), the Gates Cambridge Scholarship programme (UK), Novo-Nordisk (South Africa), Sanofi-Aventis (South Africa), and MSD Pharmaceuticals (Pty) Ltd (Southern Africa).
Funder references
MRC (MR/K013491/1)
Identifiers
External DOI: https://doi.org/10.1017/gheg.2015.3
This record's URL: https://www.repository.cam.ac.uk/handle/1810/254620
Rights
Attribution 2.0 UK: England & Wales
Licence URL: http://creativecommons.org/licenses/by/2.0/uk/
Recommended or similar items
The following licence files are associated with this item: